When comparing medications used for weight loss and diabetes management, the half-life of the drugs is a crucial factor influencing their dosing frequency and overall effectiveness. Here, we explore the half-lives of tirzepatide, semaglutide, and retatrutide based on current research and clinical data. Tirzepatide Tirzepatide is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) […]